References
- Wright P F, Kim-Farley R J, de Quadros C A, Robertson S E, Scott R M, Ward N A, Henderson R H. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 1991; 335: 1774–1779
- Lemon S M, Robertson S E. Global eradication of poliomyelitis: recent progress, future prospects and new research priorities, J L Melnick. Prog Med Virol, Basel, Karger 1991; 38: 42–55
- Hovi T. Remaining problems before eradication of poliomyelitis can be accomplished, J L Melnick. Prog Med Virol, Basel, Karger 1991; 38: 69–95
- Strebel P M, Sutter R W, Cochi S L. Epidemiology of poliomyelitis in the Unites States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992; 14: 568–579
- Faden H. Poliovirus vaccination: a trilogy. J Infect Dis 1993; 168: 25–28
- Moriniere B J, van Loon F PL, Rhodes P H, Klein-Zappan M-L, Frank-Senat B, Herrington J E, Pallansch M A, Patriarca P A. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 1993; 341: 1545–1550
- Salk D, van Wezel A L, Salle J. Induction of long term immunity to paralytic poliomyelitis by use of non-infectious vaccine. Lancet 1984; 2: 1317–1321
- McBean A M, Thomas M L, Albrecht P, Cuthie J C, Bernier R. The Field Staff and Coordinating Committee. Serological response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol 1988; 128: 615–628
- Faden H, Hodlin J F, Thomas M L, McBean A M, Ferdon M B, Ogra P L. Comparative evaluation of immunization with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 1990; 163: 1291–1297
- Tulchinsky T, Abed Y, Shaheen S, Toubassi N, Sever Y, Schoenbaum N, Handsher R. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health 1989; 79: 1648–652
- Migasena S, Simasathien S, Samakoses R, Pittisuttitham P, Sangaroon P, van Steenis G, Beuvery E C, Bugg H, Bishop R, Davidson B L, Vesikari T. Simultaneous administration of oral rhesushuman reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine, [in press]
- van der Marel P, Hazendonk A G, van Wezel A L. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods. Dev Biol Stand 1981; 47: 101–108
- Albrecht P, van Steenis G, van Wezel A L, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6: S540–544
- Rümke H C, Schlumberger M, Flowry B, Nagel J, van Steenis B. Serological evalutation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso. Vaccine 1993; 11: 1113–1118
- Patriarca P A, Wright P F, John T J. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13: 926–939
- Robertson S E, Oostvogel P. Poliomyelitis outbreaks, 1978–1988. Presented at the WHO consultation of the Eradication of poliomyelitis. September, 1989; 12–14, Geneva. Document WHO/EPI/POLIO/WP89.9/SEPT
- Robertson S E, Traverso H P, Drucker J A, Rovira E Z, Fabre-Teste B, Sow A, N'Diaye M, Sy M TA, Diouf F. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine. Lancet 1988; 1: 897–899
- Onorato I M, Modlin J F, McBean A M, Thoms M L, Losonsky G A, Bernier R H. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163: 1–6